Back

Phenotypic characterization of pulmonary hypertension associated with left heart disease in contemporary practice: insights from the Re‑PHIRE Trial

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension associated with left heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne (Germany)

5 More presentations in this session

Presentation thumbnail
Diagnosing post-capillary pulmonary hypertension in the era of mild pulmonary hypertension: what is the optimal threshold of resting pulmonary arterial wedge pressure?
Doctor S. Taya (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Right heart dimensions and pulmonary arterial wedge pressure in pulmonary arterial hypertension: exploring a controversial relationship
Assistant Professor S. Papa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Viscosity-corrected pulmonary vascular resistance: a prognostic marker in left ventricular assist device candidates
Doctor B. Lakatos (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Deep phenotyping of the right ventricular–pulmonary circulation reveals biological overlap between pulmonary arterial hypertension and combined post-capillary pulmonary hypertension
Doctor J. Rodriguez Arias (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Clinical and morphological profiles in different hemodynamic types of pulmonary hypertension in patients with mitral valve disease and predictors of persistent pulmonary hypertension post-surgery
Doctor S. Barbarash (Las Vegas, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension associated with left heart disease

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Re PHIRE – AZD3427 in heart failure with pulmonary hypertension group 2
9 May 2026
thumbnail
Congress Presentation
Clinical features of late-onset pulmonary hypertension after successful left-sided valve surgery
30 August 2026
thumbnail
Congress Presentation
Reduced right ventricular ejection fraction predicts incident heart failure and mortality in individuals without prevalent heart failure: a propensity score-matched UK Biobank analysis
31 August 2026
thumbnail
Congress Presentation
Pulmonary hypertension in patients with heart failure with reduced ejection fraction: impact of the new definition of pulmonary hypertension
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources